Tolvaptan: A selective vasopressin type 2 receptor antagonist in congestive heart failure

Umamahesh C. Rangasetty, Mihai Gheorghiade, Barry F. Uretsky, Cesare Orlandi, Alejandro Barbagelata*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Fingerprint Dive into the research topics of 'Tolvaptan: A selective vasopressin type 2 receptor antagonist in congestive heart failure'. Together they form a unique fingerprint.

Medicine & Life Sciences